The LRG Stresses Management of Side Effects
We are in the midst of one of the most exciting times in history to be involved in cancer research. Over 60 anti-cancer drugs have gained FDA-approval in the last 10 years, and that [...]
We are in the midst of one of the most exciting times in history to be involved in cancer research. Over 60 anti-cancer drugs have gained FDA-approval in the last 10 years, and that [...]
The Life Raft Group is pleased to announce the release of the ninth issue of The GIST Cancer Journal, the official journal of the Life Raft Group. The journal is intended to serve as [...]
A recent study published in the American Journal of Clinical Oncology found that the use of adjuvant systemic therapy with imatinib for GIST has increased significantly over time, and that patients treated with the [...]
Michelle Durborow with Rodrigo Salas, LRG board member, at tenth annual ICORD meeting. The tenth annual ICORD meeting was held in Mexico City on October 13-14 with the theme “A Decade of Discoveries and [...]
The Life Raft Group is excited to announce that our Virtual GIST Tumor Boards have been so successful within the global Pediatric GIST community that we are now expanding our applications to review adult GIST [...]
Presentation by Dr. Breelyn Wilky, Assistant Professor, Sarcoma Program & Member, Molecular Oncology and Experimental Theraputics (MOET) Program, Sylvester Comprehensive Cancer Center. Over 80 GISTers and their loved ones gathered from all over [...]
The Life Raft Group joins the global community in honoring World Cancer Day 2015.We join with everyone in the cancer community: researchers, physicians, advocates, patient organizations, government agencies, and most importantly, patient and caregivers to [...]
updated 1/20/21 Dr. mOe is an author, survivor, and dynamic mOe-tivational speaker. Diagnosed with GIST in 2012, Dr. mOe believes that God does not waste wounds. She is a freelance journalist, coach, mentor, [...]
The National Health Service (NHS) in the United Kingdom has announced plans to halt funding through the Cancer Drug Fund for regorafenib (Stivarga), thereby preventing GIST patients from having access to this life-saving medication.We at [...]
A recent study from MD Anderson provides insight into a protein complex that plays a significant role in cancer.In the study at the University of Texas MD Anderson Cancer center, similarities were drawn between bean [...]